Tag Archive for: Minervax

AMR

€72M from Novo´s REPAIR Impact Fund for Group B Streptococcus vaccines

MinervaX inks €72m financing deal with Novo Holdings REPAIR Impact Fund to develop a vaccine against Group B Streptococcus.

Read more